Merit Medical Systems Earnings & Forecasts

Merit Medical Systems (MMSI) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q3	Oct 29, 2026	$1.12	$1.01	10.9 %
Q2	Jul 30, 2026	$1.19	$0.94	26.6 %
Q1	Apr 30, 2026	$0.94	$0.81	16.1 %
Q4	Feb 24, 2026	$1.04	$0.91	14.3 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q3	Oct 29, 2026	$416.24M	$410.38M	1.43 %
Q2	Jul 30, 2026	$418.84M	$405.22M	3.36 %
Q1	Apr 30, 2026	$381.88M	$377.49M	1.16 %
Q4	Feb 24, 2026	$393.94M	$390.88M	0.78 %

Merit Medical Systems Guidance

Merit Medical Systems (MMSI)은 지난 10월 29, 2026에 fiscal year 2026의 실적 전망을 발표했습니다. 회사는 주당순이익을 $4.33 - $4.37 범위로 전망했으며, 이는 시장 컨센서스 EPS 추정치인 $4.21보다 높은 수치입니다. Merit Medical Systems는 또한 해당 기간의 매출을 $1.64B - $1.64B 범위로 전망했습니다.

이전 가이던스와 비교하여 Merit Medical Systems는 주당순이익(EPS) 전망치를 이전 범위인 상향 조정됨에서 $4.25 - $4.35로 상향 조정했습니다. 매출 측면에서는 회사가 매출 전망치를 이전 범위인 유지됨에서 $1.63B - $1.64B로 상향 조정했습니다.

Merit Medical Systems은 24과 2월 22, 2023 사이에 10월 29, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 11 times and lowered it 4 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q3 '26	Q2 '26	Q1 '26	Q4 '25
Earnings Per Share (Non-GAAP)
Estimate	$1.01	$0.94	$0.81	$0.91
Actual	$1.12	$1.19	$0.94	$1.04
Surprise	+10.9%	+26.6%	+16.1%	+14.3%
Revenue
Estimate	$410.4M	$405.2M	$377.5M	$390.9M
Actual	$416.2M	$418.8M	$381.9M	$393.9M
Surprise	+1.43%	+3.36%	+1.16%	+0.78%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q4 '26E	Q1 '27E	Q2 '27E	Q3 '27E
Earnings Per Share (Non-GAAP)
Consensus	$1.09	$1.00	$1.07	$1.04
Revenue
Consensus	$422.9M	$408.3M	—	—

Earnings & Guidance News

These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results

Merit Medical beat Q3 estimates, raised FY2026 EPS guidance, narrowed sales outlook; analysts lifted price targets to $110 and $106.

Avi Kapoor

PRO
Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.25-$4.35 to $4.33-$4.37 vs $4.30 Est; Narrows FY2026 Sales Guidance from $1.631B-$1.643B to $1.635B-$1.642B vs $1.636B Est

Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.25-$4.35 to $4.33-$4.37 vs $4.30 analyst estimate. Narrows FY2026 sales outlook from $1.631 billion-$1.643 billion to $1.635 billion-$1.642

Benzinga Newsdesk

PRO
Merit Medical Systems Q3 Adj. EPS $1.12 Beats $1.03 Estimate, Sales $416.244M Beat $410.376M Estimate

Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.03 by 8.74 percent. This is a 21.74 percent increase over earnings of $0.92 per share

Benzinga Newsdesk

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results

Merit Medical Systems Inc (NASDAQ: MMSI) reported strong Q2 earnings, beating estimates with raised guidance. Analysts maintain Buy ratings with increased price targets.

Avi Kapoor

PRO
Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 Est; Raises FY2026 Sales Guidance from $1.612B-$1.634B to $1.631B-$1.643B vs $1.620B Est

Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 analyst estimate. Raises FY2026 sales outlook from $1.612 billion-$1.634 billion to $1.631 billion-$1.643

Benzinga Newsdesk

PRO
Merit Medical Systems Q2 Adj. EPS $1.19 Beats $0.96 Estimate, Sales $418.843M Beat $405.268M Estimate

Benzinga Newsdesk

Merit Medical Systems Inc

뉴스

파트너 / 기고자

벤징가 글로벌